Minor tranquillizers in somatic disorders.
Conclusive evidence of improved outcome due to adjunctive anxiolytic therapy in some somatic conditions is lacking. However, such therapy may facilitate patient management without being "curative". The resulting improved feeling of well-being may be of value in the management of gastrointestinal disorders, migraine and myocardial infarction. Negative effects may be observed in acute respiratory conditions, especially during acute exacerbations of chronic conditions, with the administration of benzodiazepines; hence they should be used with caution. The use of these agents in treating persons with hypertension seems to be of no value and may even be detrimental. Careful evaluation of each case is desirable, and treatment should be planned with its termination in mind.
D000787:Angina Pectoris / Q000188:drug therapy; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008881:Migraine Disorders / Q000188:drug therapy; D009203:Myocardial Infarction / Q000188:drug therapy; D012140:Respiratory Tract Diseases / Q000188:drug therapy
D014151:Anti-Anxiety Agents